Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

112.69
Delayed Data
As of May 24
 +0.53 / +0.47%
Today’s Change
81.79
Today|||52-Week Range
115.00
+9.71%
Year-to-Date
Novartis Filing for MabThera Biosimilar Accepted in the EU
May 24 / Zacks.com - Paid Partner Content
3 Perfect Stocks for Retirees in Their 60s to Consider Buying
May 17 / MotleyFool.com - Paid Partner Content
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II
May 24 / Zacks.com - Paid Partner Content
The 3 Best Dividend Mutual Funds
May 17 / MotleyFool.com - Paid Partner Content
5 Smart IRA Moves You Can Make Now
May 24 / MotleyFool.com - Paid Partner Content
Aegerion (AEGR) Misses Q1 Earnings Estimates, Cuts View
May 17 / Zacks.com - Paid Partner Content
4 Dow Members Bucking the Negative Trend
May 24 / Zacks.com - Paid Partner Content
Novartis (NVS) Releases Positive Data on Ultibro Breezhaler
May 16 / Zacks.com - Paid Partner Content
3 Stocks With Better Dividends Than Johnson & Johnson
May 24 / MotleyFool.com - Paid Partner Content
Drug Stocks Reporting Earnings on May 17: AXON & FWP
May 16 / Zacks.com - Paid Partner Content
Ignore Intuitive Surgical, Inc.: Here Are 3 Better Stocks
May 23 / MotleyFool.com - Paid Partner Content
The 3 Best Dividend ETFs
May 15 / MotleyFool.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
Smart Investors Are Already Buying These Stocks for Retirement
May 15 / MotleyFool.com - Paid Partner Content
Triple-A quality fades as companies embrace debt
May 23 / FT.com - Paid Partner Content
Vanguard Total Stock Market Index Fund -- Investing in Stocks the Easy Way
May 14 / MotleyFool.com - Paid Partner Content
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market
May 22 / GuruFocus News - Paid Partner Content
Europe's corporate bond market hums ahead of ECB
May 13 / FT.com - Paid Partner Content
The 3 Best Retirement Funds for Your 401(k)
May 21 / MotleyFool.com - Paid Partner Content
Google is worth more than Apple again
May 12 / CNNMoney.com
One Reason Why Johnson & Johnson (JNJ) Stock Is Retreating Today
May 20 / TheStreet.com - Paid Partner Content
Why Endo International plc Investigated a Lower Price
May 11 / MotleyFool.com - Paid Partner Content
An unhappy anniversary for the bull market
May 20 / CNNMoney.com
3 ETFs to Help You Build Retirement Wealth
May 11 / MotleyFool.com - Paid Partner Content
In Your 60s? 3 Stocks You Should Consider Buying
May 20 / MotleyFool.com - Paid Partner Content
Drug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY
May 11 / Zacks.com - Paid Partner Content
Roche Gets Accelerated Approval for Immunotherapy Drug
May 19 / Zacks.com - Paid Partner Content
What now for the dollar: big questions for markets this week
May 08 / FT.com - Paid Partner Content
Will Johnson & Johnson (JNJ) Stock Rise as Wells Fargo Sees Solid Growth?
May 19 / TheStreet.com - Paid Partner Content
 Johnson & Johnson loses second cancer lawsuit
May 03 / CNNMoney.com
J&J's Consumer, Medical Device Businesses Will Drive Growth
May 19 / TheStreet.com - Paid Partner Content
Don't get too used to a weak dollar
Apr 27 / CNNMoney.com
4 Healthy Dividend Stocks For Your Portfolio
May 18 / TheStreet.com - Paid Partner Content
S&P strips ExxonMobil of coveted triple A rating
Apr 26 / FT.com - Paid Partner Content
4 Healthy Dividend Stocks For Your Portfolio
May 18 / TheStreet.com - Paid Partner Content
ExxonMobil loses perfect AAA rating after 67 years
Apr 26 / CNNMoney.com
Bear of the Day: AbbVie (ABBV)
May 18 / Zacks.com - Paid Partner Content
Big Food in health drive to keep market share
Apr 25 / FT.com - Paid Partner Content
Catalyst (CPRX) Resorts to Layoffs for Firdapse Development
May 18 / Zacks.com - Paid Partner Content